Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (211-220 of 290) with videos related to

Pageof 29
Sort By:
The Journal of Antimicrobial Chemotherapy|May 23, 2013
Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosisLaura J Sherrard, Kathryn A Graham, Stef J McGrath, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 24, 2026
Mucoactive agents in bronchiectasis: a systematic review and meta-analysisBenjamin McCullough, John Busby, Brenda O'Neill, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2026
Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS TrialGisli G Einarsson, Andrew J Lee, Zina Alfahl, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2016
Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis AirwaysJames A Reihill, Brian Walker, Robert A Hamilton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 30, 2018
Defining antimicrobial resistance in cystic fibrosisTimothy J Kidd, Rafael Canton, Miquel Ekkelenkamp, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 14, 2011
Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patientsHarriet Corvol, Julie Beucher, Pierre-Yves Boëlle, et al.
Experimental Dermatology|May 23, 2014
SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitroDonal O'Kane, Megan V Jackson, Adrien Kissenpfennig, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 28, 2018
Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV<sub>1</sub>Susanna A McColley, Michael W Konstan, Bonnie W Ramsey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2019
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung InfectionsValerie J Waters, Timothy J Kidd, Rafael Canton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 3, 2019
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic reviewRanjani Somayaji, Michael D Parkins, Anand Shah, et al.
Pageof 29

Showing results (211-220 of 290) with videos related to

Sort By:
Pageof 29
The Journal of Antimicrobial Chemotherapy|May 23, 2013
Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosisLaura J Sherrard, Kathryn A Graham, Stef J McGrath, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 24, 2026
Mucoactive agents in bronchiectasis: a systematic review and meta-analysisBenjamin McCullough, John Busby, Brenda O'Neill, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2026
Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS TrialGisli G Einarsson, Andrew J Lee, Zina Alfahl, et al.
American Journal of Respiratory and Critical Care Medicine|March 26, 2016
Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis AirwaysJames A Reihill, Brian Walker, Robert A Hamilton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 30, 2018
Defining antimicrobial resistance in cystic fibrosisTimothy J Kidd, Rafael Canton, Miquel Ekkelenkamp, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 14, 2011
Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patientsHarriet Corvol, Julie Beucher, Pierre-Yves Boëlle, et al.
Experimental Dermatology|May 23, 2014
SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitroDonal O'Kane, Megan V Jackson, Adrien Kissenpfennig, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 28, 2018
Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV<sub>1</sub>Susanna A McColley, Michael W Konstan, Bonnie W Ramsey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2019
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung InfectionsValerie J Waters, Timothy J Kidd, Rafael Canton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 3, 2019
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic reviewRanjani Somayaji, Michael D Parkins, Anand Shah, et al.
Pageof 29